Cite
MLA Citation
Chloe Orkin et al.. “Fixed-dose combination bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir-containing regimens for initial treatment of HIV-1 infection: week 144 results from two randomised, double-blind, multicentre, phase 3, non-inferiority trials.” Lancet, vol. 7, no. 6, 2020, pp. e389–e400. http://access.bl.uk/ark:/81055/vdc_100103941073.0x000002